Sirona Biochem Corp Market Cap ($11.23 Million)
Market Cap & Net Worth: Sirona Biochem Corp (SBM)
Sirona Biochem Corp market cap. Sirona Biochem Corp (V:SBM) has a market capitalization of $11.23 Million (CA$15.53 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #26653 globally and #1076 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sirona Biochem Corp's stock price CA$0.06 by its total outstanding shares 258843825 (258.84 Million). Also see Sirona Biochem Corp cash flow conversion for how efficiently the company converts equity into cash flow.
Sirona Biochem Corp Market Cap History (2015–2025)
Sirona Biochem Corp market cap history from 2015 to 2025. Data shows change from $33.70 Million to $11.23 Million (-10.21% CAGR). Check SBM stock price and chart for real-time trading data and today's change.
Sirona Biochem Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sirona Biochem Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Sirona Biochem Corp to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
646.06x
Sirona Biochem Corp's market cap is 646.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $33.70 Million | $8.00K | -$3.66 Million | 4215.62x | N/A |
| 2016 | $26.21 Million | $360.50K | -$2.97 Million | 72.72x | N/A |
| 2017 | $19.66 Million | $5.47K | -$4.46 Million | 3595.57x | N/A |
| 2018 | $15.92 Million | $1.28 Million | -$1.27 Million | 12.45x | N/A |
| 2019 | $82.39 Million | $135.74K | -$4.55 Million | 606.94x | N/A |
| 2020 | $60.85 Million | $105.71K | -$4.13 Million | 575.67x | N/A |
| 2021 | $32.77 Million | $268.02K | -$2.31 Million | 122.26x | N/A |
| 2022 | $21.53 Million | $671.92K | -$3.56 Million | 32.05x | N/A |
| 2023 | $22.47 Million | $34.78K | -$2.54 Million | 646.06x | N/A |
Competitor Companies of SBM by Market Capitalization
Companies near Sirona Biochem Corp in the global market cap rankings as of November 1, 2026. Also see SBM asset base for a full breakdown of the balance sheet.
Key companies related to Sirona Biochem Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Sirona Biochem Corp (2015–2025)
Market capitalization of Sirona Biochem Corp from 2015 to today. Between 2015 and today, Sirona Biochem Corp's market cap moved from $33.70 Million to $ 11.23 Million, with a yearly change of -10.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | CA$11.23 Million | 0.00% |
| 2024 | CA$11.23 Million | -50.00% |
| 2023 | CA$22.47 Million | +4.35% |
| 2022 | CA$21.53 Million | -34.29% |
| 2021 | CA$32.77 Million | -46.15% |
| 2020 | CA$60.85 Million | -26.14% |
| 2019 | CA$82.39 Million | +417.65% |
| 2018 | CA$15.92 Million | -19.05% |
| 2017 | CA$19.66 Million | -25.00% |
| 2016 | CA$26.21 Million | -22.22% |
| 2015 | CA$33.70 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 24th, 2026 the market cap of Sirona Biochem Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.23 Million USD |
| MoneyControl | $11.23 Million USD |
| MarketWatch | $11.23 Million USD |
| marketcap.company | $11.23 Million USD |
| Reuters | $11.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more